Obesema 0.25mg Injection
Available Pack Sizes
Free Shipping
Order above $200.00
Worldwide Delivery
8-10 Business Days
24/7 Support
Solve your queries
- 100% Genuine Medicines
- Secure International Logistics
- Secure Payment
- Authentic Pharmaceutical Supplier
How to Order from Medionix Pharma
Add Products
Browse our medicines and add the required products to your cart.
Add Products to Cart
Order Method
Place your order easily through WhatsApp or Email support.
Choose Your Ordering Method
Share Details
Provide your delivery address and contact information.
Share Delivery & Prescription Details
Order Dispatched
Your order is packed securely and shipped worldwide.
Order Confirmation & Dispatch
Obesema 0.25mg Injection
contains Semaglutide 0.25mg per weekly dose in a pre-filled pen, manufactured by Abbott. This is the recommended starting dose for GLP-1 receptor agonist therapy, used for 4 weeks to allow the body to adapt before escalating to higher maintenance doses. Abbott's manufacturing standards ensure precise dose delivery and consistent product quality.
Benefits:
- Establishes GLP-1 tolerance with minimal gastrointestinal side effects during initiation
- Reduces appetite and improves glycaemic control from the very first week
- Once-weekly subcutaneous injection for maximum adherence
- Manufactured by Abbott — a globally trusted pharmaceutical brand
- Affordable entry point into semaglutide therapy
How It Works:
Semaglutide binds to GLP-1 receptors in the brain and pancreas, reducing appetite, slowing gastric emptying, and stimulating glucose-dependent insulin secretion. At 0.25mg, the effect is sufficient for tolerance establishment without significant weight-loss impact; metabolic benefits accumulate as the dose is titrated upward.
Dosage and Administration:
Inject 0.25mg subcutaneously once weekly for 4 weeks. Administer into the abdomen, thigh, or outer upper arm at any time of day with or without food. Rotate injection sites each week. After 4 weeks, progress to 0.5mg as directed.
Side Effects:
Common: nausea, diarrhoea, vomiting, constipation, abdominal discomfort. Uncommon: headache, fatigue, dizziness. Serious: pancreatitis, gallbladder disease, medullary thyroid tumour risk.
Precautions:
Contraindicated in personal or family history of medullary thyroid carcinoma or MEN2. Use with caution in renal impairment. Not recommended during pregnancy or breastfeeding.
Obesema Dosage Comparison Guide
| Strength | Best For | Onset | Duration | Link |
|---|---|---|---|---|
| 0.25mg | Lower strength option | 2–4 wks | Weekly | Current |
| 0.5mg | Standard strength option | 2–4 wks | Weekly | View → |
| 1mg | Popular strength option | 2–4 wks | Weekly | View → |
| 1.7mg | Higher strength option | 2–4 wks | Weekly | View → |
| 2.4mg | Maximum strength variant | 2–4 wks | Weekly | View → |
* Always consult your doctor before changing your dosage. This information is for educational reference only.
Frequently Asked Questions
Q1: What is Obesema 0.25mg used for?
Obesema 0.25mg is the initiation dose of injectable semaglutide by Abbott, used for the first 4 weeks of GLP-1 therapy to allow gastrointestinal tolerance to develop before escalating to the 0.5mg maintenance dose.
Q2: Will I lose weight on Obesema 0.25mg?
The 0.25mg dose is primarily a tolerance-building phase. Most patients experience modest appetite reduction but significant weight loss typically begins after dose escalation to 0.5mg and beyond.
Q3: Can I stay on Obesema 0.25mg permanently?
No. The 0.25mg dose is not recommended for long-term maintenance; it is an initiation dose only. After 4 weeks your prescriber will typically advance you to 0.5mg for therapeutic benefit.
Q4: How does Obesema compare to Ozempic 0.25mg?
Obesema 0.25mg contains the same semaglutide active ingredient at the same initiation dose as Ozempic 0.25mg. As an equivalent product by Abbott, it delivers the same tolerability profile at substantially lower cost.
Q5: What should I do if I miss an Obesema 0.25mg dose?
If you miss a weekly dose, inject it within 5 days of the missed date. If more than 5 days have passed, skip the missed dose and resume your regular weekly schedule. Do not double-dose.
Customer Reviews
Dr. Emily Parker
UK · 2 months ago
“Impressed with the professionalism. Certificate of Analysis provided on request. Will be placing repeat orders for our clinic.”
Metro Hospital Pharmacy
UK · 2 weeks ago
“Reliable supplier. Product met all our quality standards. Great communication throughout the entire procurement process.”
Global Meds Supply
Germany · 6 weeks ago
“Ordering from Medionix for several months now. Consistent pharmaceutical quality and professional service every time.”
Thomas B.
Australia · 4 months ago
“Legitimate pharmaceutical supplier. Packaging intact, expiry dates clearly printed, batch numbers traceable. Very satisfied.”
Robert Chen
Canada · 1 month ago
“Very satisfied with the order. Packaging was secure and delivery was on time. Quality matches the description perfectly.”
Related Products
Disclaimer
The information provided on Medionix Pharma is intended for general informational purposes only. It should not be considered as medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before using any medication or starting any treatment.
Medionix Pharma does not encourage self-medication. Customers are responsible for ensuring that purchases comply with local laws and prescription requirements in their country. If you have any questions or concerns regarding the content on our website, please contact us at sales@medionixpharma.com.